chr16-20341727-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003361.4(UMOD):​c.1332-391C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.162 in 152,114 control chromosomes in the GnomAD database, including 2,132 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.16 ( 2132 hom., cov: 33)

Consequence

UMOD
NM_003361.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0320

Publications

7 publications found
Variant links:
Genes affected
UMOD (HGNC:12559): (uromodulin) The protein encoded by this gene is the most abundant protein in mammalian urine under physiological conditions. Its excretion in urine follows proteolytic cleavage of the ectodomain of its glycosyl phosphatidylinosital-anchored counterpart that is situated on the luminal cell surface of the loop of Henle. This protein may act as a constitutive inhibitor of calcium crystallization in renal fluids. Excretion of this protein in urine may provide defense against urinary tract infections caused by uropathogenic bacteria. Defects in this gene are associated with the renal disorders medullary cystic kidney disease-2 (MCKD2), glomerulocystic kidney disease with hyperuricemia and isosthenuria (GCKDHI), and familial juvenile hyperuricemic nephropathy (FJHN). Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2013]
UMOD Gene-Disease associations (from GenCC):
  • autosomal dominant medullary cystic kidney disease with or without hyperuricemia
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • glomerulocystic kidney disease with hyperuricemia and isosthenuria
    Inheritance: AD Classification: DEFINITIVE Submitted by: Laboratory for Molecular Medicine
  • familial juvenile hyperuricemic nephropathy type 1
    Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal dominant medullary cystic kidney disease with hyperuricemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.178 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UMODNM_003361.4 linkc.1332-391C>T intron_variant Intron 6 of 10 ENST00000396138.9 NP_003352.2 P07911-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UMODENST00000396138.9 linkc.1332-391C>T intron_variant Intron 6 of 10 5 NM_003361.4 ENSP00000379442.5 P07911-1X6RBG4
UMODENST00000396134.6 linkc.1431-391C>T intron_variant Intron 7 of 11 2 ENSP00000379438.2 P07911-5
UMODENST00000570689.5 linkc.1332-391C>T intron_variant Intron 6 of 10 5 ENSP00000460548.1 P07911-1
UMODENST00000570331.1 linkn.97-391C>T intron_variant Intron 1 of 5 5

Frequencies

GnomAD3 genomes
AF:
0.162
AC:
24684
AN:
151996
Hom.:
2121
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.126
Gnomad AMI
AF:
0.274
Gnomad AMR
AF:
0.180
Gnomad ASJ
AF:
0.148
Gnomad EAS
AF:
0.0127
Gnomad SAS
AF:
0.179
Gnomad FIN
AF:
0.224
Gnomad MID
AF:
0.199
Gnomad NFE
AF:
0.181
Gnomad OTH
AF:
0.164
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.162
AC:
24714
AN:
152114
Hom.:
2132
Cov.:
33
AF XY:
0.164
AC XY:
12185
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.126
AC:
5238
AN:
41514
American (AMR)
AF:
0.180
AC:
2750
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.148
AC:
513
AN:
3468
East Asian (EAS)
AF:
0.0123
AC:
64
AN:
5184
South Asian (SAS)
AF:
0.178
AC:
856
AN:
4814
European-Finnish (FIN)
AF:
0.224
AC:
2358
AN:
10548
Middle Eastern (MID)
AF:
0.207
AC:
61
AN:
294
European-Non Finnish (NFE)
AF:
0.181
AC:
12273
AN:
67982
Other (OTH)
AF:
0.167
AC:
352
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1038
2076
3115
4153
5191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
262
524
786
1048
1310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.166
Hom.:
3465
Bravo
AF:
0.158
Asia WGS
AF:
0.123
AC:
431
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
3.1
DANN
Benign
0.57
PhyloP100
0.032
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9928936; hg19: chr16-20353049; API